Bob L. Lobo

564 total citations
16 papers, 254 citations indexed

About

Bob L. Lobo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Bob L. Lobo has authored 16 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Internal Medicine. Recurrent topics in Bob L. Lobo's work include Venous Thromboembolism Diagnosis and Management (4 papers), Migraine and Headache Studies (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Bob L. Lobo is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (4 papers), Migraine and Headache Studies (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Bob L. Lobo collaborates with scholars based in United States. Bob L. Lobo's co-authors include Joyce E. Broyles, Ronald I. Shorr, Georgeta Vaidean, Christopher K. Finch, William L. Greene, Stephen H. Landy, Allison Lardieri, Kurt A. Wargo, Curtis E. Haas and Mikhail S. Gelfand and has published in prestigious journals such as Clinical Therapeutics, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.

In The Last Decade

Bob L. Lobo

16 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bob L. Lobo United States	9	102	77	74	50	43	16	254
Christine M. Groth United States	7	18 0.2×	36 0.5×	49 0.7×	16 0.3×	34 0.8×	23	176
Kerry K. Pickworth United States	9	13 0.1×	100 1.3×	54 0.7×	60 1.2×	205 4.8×	19	358
Rocío Figueroa United States	9	22 0.2×	14 0.2×	48 0.6×	147 2.9×	81 1.9×	18	349
Charles D. Bayliff Canada	9	13 0.1×	9 0.1×	68 0.9×	74 1.5×	101 2.3×	24	306
Kazuomi Kario Japan	12	16 0.2×	10 0.1×	52 0.7×	68 1.4×	324 7.5×	18	495
George Albert United States	8	7 0.1×	12 0.2×	78 1.1×	45 0.9×	12 0.3×	18	246
J Charvát Czechia	10	81 0.8×	17 0.2×	93 1.3×	57 1.1×	118 2.7×	51	331
A. Werba Austria	11	23 0.2×	43 0.6×	53 0.7×	136 2.7×	67 1.6×	27	323
Karen Allen United States	11	9 0.1×	11 0.1×	93 1.3×	32 0.6×	9 0.2×	29	336
Chris Zimmerman United States	5	34 0.3×	10 0.1×	18 0.2×	13 0.3×	26 0.6×	9	226

Countries citing papers authored by Bob L. Lobo

Since Specialization

Citations

This map shows the geographic impact of Bob L. Lobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob L. Lobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob L. Lobo more than expected).

Fields of papers citing papers by Bob L. Lobo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bob L. Lobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob L. Lobo. The network helps show where Bob L. Lobo may publish in the future.

Co-authorship network of co-authors of Bob L. Lobo

This figure shows the co-authorship network connecting the top 25 collaborators of Bob L. Lobo. A scholar is included among the top collaborators of Bob L. Lobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bob L. Lobo. Bob L. Lobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Neal, Erin B., et al.. (2017). The Role of Computerized Clinical Decision Support in Reducing Inappropriate Medication Administration During Epidural Therapy. Hospital Pharmacy. 53(3). 170–176. 4 indexed citations

Haas, Curtis E., Stephen F Eckel, Sally A. Arif, et al.. (2012). Acute Care Clinical Pharmacy Practice: Unit‐ versus Service‐Based Models. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(2). e35–44. 20 indexed citations

Swanson, Joseph M., et al.. (2009). Evaluation of glycemic control following discontinuation of an intensive insulin protocol. Journal of Hospital Medicine. 4(1). 28–34. 13 indexed citations

Lobo, Bob L., et al.. (2009). Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. Journal of Hospital Medicine. 4(7). 417–422. 97 indexed citations

Howard-Thompson, Amanda, Justin B. Usery, Bob L. Lobo, & Christopher K. Finch. (2008). Heparin-induced thrombocytopenia complicated by warfarin-induced skin necrosis. American Journal of Health-System Pharmacy. 65(12). 1144–1147. 7 indexed citations

Finch, Christopher K., et al.. (2007). Blood pressure management in acute hypertensive emergency. American Journal of Health-System Pharmacy. 64(24). 2579–2582. 17 indexed citations

Lobo, Bob L.. (2007). Use of newer anticoagulants in patients with chronic kidney disease. American Journal of Health-System Pharmacy. 64(19). 2017–2026. 9 indexed citations

Lobo, Bob L., et al.. (2006). Overuse of Antihypertensives in Patients with Acute Ischemic Stroke. Southern Medical Journal. 99(11). 1230–1233. 8 indexed citations

Landy, Stephen H. & Bob L. Lobo. (2005). Migraine treatment throughout the lifecycle. Expert Review of Neurotherapeutics. 5(3). 343–353. 7 indexed citations

10.

Lobo, Bob L.. (2004). Emerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(7P2). 66S–72S. 2 indexed citations

11.

Finch, Christopher K. & Bob L. Lobo. (2004). Acute Inhalant-Induced Neurotoxicity with Delayed Recovery. Annals of Pharmacotherapy. 39(1). 169–172. 17 indexed citations

12.

Lobo, Bob L.. (2003). Pharmacoeconomic considerations. American Journal of Health-System Pharmacy. 60(suppl_7). S11–S14. 3 indexed citations

13.

Lobo, Bob L., et al.. (1999). Symptomatic pharmacotherapy of migraine. Clinical Therapeutics. 21(7). 1118–1130. 11 indexed citations

14.

Lobo, Bob L. & William L. Greene. (1997). Zolpidem: Distinct from Triazolam?. Annals of Pharmacotherapy. 31(5). 625–632. 32 indexed citations

15.

Clark, Allan, Bob L. Lobo, & Mikhail S. Gelfand. (1996). Fluconazole and Amphotericin B for Cryptococcal Meningitis. Annals of Pharmacotherapy. 30(12). 1408–1410. 6 indexed citations

16.

Lobo, Bob L., et al.. (1994). Recommendations for the emergency treatment of migraine headache.. PubMed. 87(2). 53–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact